Access to medication in Mexico: financing and equity

Por favor, use este identificador para citar o enlazar este ítem: https://ri.ujat.mx/handle/20.500.12107/1973

Registro completo de metadatos

Campo DC	Valor	Lengua/Idioma
dc.rights.license	http://creativecommons.org/licenses/by-nc/4.0	es_MX
dc.date.accessioned	2018-04-10T03:29:50Z	-
dc.date.available	2018-04-10T03:29:50Z	-
dc.identifier.uri	http://ri.ujat.mx//handle/20.500.12107/1973	-
dc.description	Abstract: This paper presents some characteristics of the financing and access to medication in Mexico. It also shows the level of prices and costs of diabetes treatment. This study is based on the national survey about the income and expense of hoseholds from 1998 and 2010. The poorest households without social security, have an expense in medication relatively higher than the rest of the population which seems to be unfair. The cost of diabetes treatment with drugs without patent is too high.	-
dc.rights	info:eu-repo/semantics/openAccess	es_MX
dc.title	Access to medication in Mexico: financing and equity	-
Aparece en las colecciones:	Vol. 15, Núm. 2 (2016)

Ficheros en este ítem:

Fichero	Descripción	Tamaño	Formato
05-pdf_5-A.pdf		725,95 kB	Adobe PDF	Visualizar/Abrir